15 October 2020

Roche Will Be `Thoughtful' on Regeneron Pricing, CEO Says

WTF is "thoughtful"?
Oct.15 -- Roche Holding AG Chief Executive Officer Severin Schwan discusses the antibody cocktail that the Swiss drugmaker is developing with Regeneron Pharmaceuticals Inc. to treat Covid-19. He speaks from Basel, Switzerland, on "Bloomberg Markets: European Open" after Roche's third-quarter sales fell short of estimates.
606 views
Oct 15, 2020 @ time of upload to this blog

No comments:

PHOTONIC TIME CRYSTALS: This research challenges the boundaries of how we can control the light-matter interaction

Scientists Create Photonic Time Crystals That Amplify Light Exponentially By  Aalto University November 15, 2024 1 Comment 3 Mins Read Faceb...